Home > Insider Trading > Filing (0000914190-12-000512)

Filing Details

Accession Number:: 0000914190-12-000512
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-23 17:45:07
Reporting Period:: 2012-08-21

Filing Date:: 2012-08-23
Accepted Time:: 2012-08-23 17:45:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180145	Cardiovascular Systems Inc	CSII	Surgical & Medical Instruments & Apparatus (3841)	411698056

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1427556	E James Flaherty	651 Campus Drive St. Paul MN 55112	Chief Administrative Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-08-21	2,233	$9.19	147,874	No	4	S	Direct
Common Stock	Disposition	2012-08-22	378	$9.02	147,496	No	4	S	Direct
Common Stock	Disposition	2012-08-23	1,407	$8.90	146,089	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$8.83	2016-12-18	9,381	9,381	Direct
Common Stock	Stock Option (right to buy)	$8.83	2017-04-17	25,233	25,233	Direct
Common Stock	Stock Option (right to buy)	$7.90	2017-08-06	22,645	22,645	Direct
Common Stock	Stock Option (right to buy)	$12.15	2017-12-11	32,350	32,350	Direct
Common Stock	Stock Option (right to buy)	$8.75	2019-03-02	10,999	10,999	Direct
Common Stock	Stock Option (right to buy)	$9.28	2014-11-15	4,852	4,852	Direct
Common Stock	Stock Option (right to buy)	$12.37	2015-06-30	16,175	16,175	Direct
Common Stock	Stock Option (right to buy)	$12.37	2015-11-07	7,764	7,764	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-12-18	9,381	9,381	Direct
2017-04-17	25,233	25,233	Direct
2017-08-06	22,645	22,645	Direct
2017-12-11	32,350	32,350	Direct
2019-03-02	10,999	10,999	Direct
2014-11-15	4,852	4,852	Direct
2015-06-30	16,175	16,175	Direct
2015-11-07	7,764	7,764	Direct

Footnotes

In connection with the vesting and delivery of restricted stock, and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2012, on each date shares were sold and the net proceeds were used to pay required withholding taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.39 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.08 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.74 to $8.99 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.